User profiles for S. Armesto

Susana .Armesto

Hospital Universitario Marqués de Valdecilla
Verified email at scsalud.es
Cited by 1380

Redefining the therapeutic objective in psoriatic patients candidates for biological therapy

…, A López-Ferrer, F Peral, S Armesto… - Journal of …, 2018 - Taylor & Francis
The advances in psoriasis management currently allow achieving a good control of the disease.
In particular, with the latest developed molecules, available evidence suggests that it is …

[HTML][HTML] The essential role of IL-17 as the pathogenetic link between psoriasis and metabolic-associated fatty liver disease

…, S Benlloch, J Ampuero, JA Suárez-Pérez, S Armesto… - Life, 2023 - mdpi.com
… Disclaimer/Publisher’s Note: The statements, opinions and data contained in all … author(s)
and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim …

Henoch-Schönlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center

…, H Fernández-Llaca, MA González-López, S Armesto… - Medicine, 2014 - journals.lww.com
The severity of clinical features and the outcomes in previous series of patients reported with
Henoch-Schönlein purpura (HSP) vary greatly, probably due to selection bias. To establish …

[HTML][HTML] Nail psoriasis in individuals with psoriasis vulgaris: a study of 661 patients

S Armesto, A Esteve, P Coto-Segura, M Drake… - Actas Dermo …, 2011 - Elsevier
BACKGROUND AND OBJECTIVES: The nails are affected in a substantial number of patients
with psoriasis. Nevertheless, few epidemiological studies have reported the characteristics …

[HTML][HTML] Relapses in patients with Henoch–Schönlein purpura: analysis of 417 patients from a single center

…, MA González-López, S Armesto… - Medicine, 2016 - journals.lww.com
To further investigate into the relapses of Henoch–Schönlein purpura (HSP), we analyzed the
frequency, clinical features, and predictors of relapses in series of 417 unselected patients …

Anti‐TNF‐α therapy improves insulin sensitivity in non‐diabetic patients with psoriasis: a 6‐month prospective study

T Pina, S Armesto, R Lopez‐Mejias… - Journal of the …, 2015 - Wiley Online Library
Objective Psoriasis is a chronic inflammatory disease associated with increased risk of
cardiovascular death. Several studies have shown a beneficial effect of anti‐ TNF ‐α therapy on …

Anti‐tumor necrosis factor‐alpha therapy improves endothelial function and arterial stiffness in patients with moderate to severe psoriasis: a 6‐month prospective …

…, A Corrales, R Lopez‐Mejias, S Armesto… - The Journal of …, 2016 - Wiley Online Library
The aim of the present study was to determine if the use of the anti‐tumor necrosis factor (
TNF )‐α monoclonal antibody adalimumab could improve endothelial function and arterial …

Psoriasis flare after influenza vaccination in Covid‐19 era: a report of four cases from a single center

…, M Drake‐Monfort, S Armesto… - Dermatologic …, 2021 - ncbi.nlm.nih.gov
Dear Editor, Psoriasis is a chronic inflammatory disease affecting 1% to 3% of the world's
population1, 2 and results from the interaction between genetics and environmental factors …

COVID‐19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain

R Queiro Silva, S Armesto… - Dermatologic …, 2020 - Wiley Online Library
Immunosuppressive and immunomodulatory treatments are critical for the management of
inflammatory and autoimmune conditions such as psoriasis or psoriatic arthritis. Similar to …

Urticarial vasculitis in northern Spain: clinical study of 21 cases

…, L Alvarez, MC González-Vela, S Armesto… - Medicine, 2014 - journals.lww.com
Urticarial vasculitis (UV) is a subset of cutaneous vasculitis (CV), characterized clinically by
urticarial skin lesions of more than 24 hours’ duration and histologically by leukocytoclastic …